艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复
 |
| 图示∶2011年5月正式出版的《中国特色医疗金鉴》登载的刘君主任及其机构事迹 |
| |
|
|
Sino-US cooperation in the exploration to prevent mother to child transmission of AIDS and hepatitis B New Technology
September 20, 2011 18:41:25 Source: Xinhua
NANNING, September 20 (Reporter-way group) September 20, from Guangxi and the U.S. CDC (CDC), National Maternal and Child Health Center, the National AIDS Centre CDC-joint of AIDS and hepatitis B prevention of mother to child blocking drug research - "to use tenofovir during pregnancy" topic in Guangxi to start.
According to Gan Lin, deputy director of Guangxi Zhuang Autonomous Region Health Department introduced this research is the international's first PMTCT prevention of HIV and hepatitis B drug research, the combined HIV (human immunodeficiency virus)-HBV (hepatitis B virus) infected mothers to use tenofovir antiviral therapy in late pregnancy in the PMTCT, HIV and HBV co-infection for mothers and their babies very large health benefits. Topic started, the subject of the formal implementation of the 3-year clinical study.
Guangxi Zhuang Autonomous Region Health Department statistics show that from February 1, 2010 since the implementation of free premarital, Guangxi has 1.22 million to provide pre-marital HIV antibody testing, pre-marital HIV testing rate of persons 99.36%; to this year 2010 August, has 1.263 million to provide HIV antibody testing pregnant women, maternal antibody 97.52% detection rate.
Gan said that Guangxi is a high incidence of AIDS and hepatitis B, AIDS and hepatitis B from the high-risk groups to the general population, women infected with HIV and hepatitis B rapid increase in number by the number of people infected mother to child transmission is also increasing rapidly, the new situation prevention of mother to child transmission of AIDS and hepatitis B work a greater challenge.
